JP2025525989A5 - - Google Patents
Info
- Publication number
- JP2025525989A5 JP2025525989A5 JP2025507000A JP2025507000A JP2025525989A5 JP 2025525989 A5 JP2025525989 A5 JP 2025525989A5 JP 2025507000 A JP2025507000 A JP 2025507000A JP 2025507000 A JP2025507000 A JP 2025507000A JP 2025525989 A5 JP2025525989 A5 JP 2025525989A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22188990.0A EP4316505A1 (en) | 2022-08-05 | 2022-08-05 | Intranasal administration of ngf for the treatment of sensorineural hearing loss |
| EP22188990.0 | 2022-08-05 | ||
| PCT/EP2023/071698 WO2024028487A1 (en) | 2022-08-05 | 2023-08-04 | Intranasal administration of ngf for the treatment of sensorineural hearing loss |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025525989A JP2025525989A (ja) | 2025-08-07 |
| JPWO2024028487A5 JPWO2024028487A5 (https=) | 2026-04-20 |
| JP2025525989A5 true JP2025525989A5 (https=) | 2026-04-20 |
Family
ID=82846594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025507000A Pending JP2025525989A (ja) | 2022-08-05 | 2023-08-04 | 感音性難聴の治療のためのｎｇｆの鼻腔内投与 |
Country Status (7)
| Country | Link |
|---|---|
| EP (2) | EP4316505A1 (https=) |
| JP (1) | JP2025525989A (https=) |
| CN (1) | CN119836297A (https=) |
| AU (1) | AU2023317864A1 (https=) |
| CA (1) | CA3263975A1 (https=) |
| IL (1) | IL318657A (https=) |
| WO (1) | WO2024028487A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4659759A1 (en) * | 2024-06-04 | 2025-12-10 | Dompé farmaceutici SpA | Administration of ngf for the treatment of niemann-pick type c disease |
| WO2026022244A1 (en) | 2024-07-23 | 2026-01-29 | Chiesi Farmaceutici S.P.A. | A polypeptide for use in the therapeutic management of acute ischaemic stroke |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2213861T3 (es) | 1998-10-09 | 2004-09-01 | Scil Proteins Gmbh | Procedimiento de obtencion de ngf-beta activa. |
| ITRM20110390A1 (it) * | 2011-07-21 | 2013-01-22 | Eramo Alessandra D | Prodotto per stimolare la produzione endogena di mediatori dell'infiammazione. |
| CN104203264B (zh) | 2011-12-19 | 2018-08-28 | 瓦克化学有限公司 | 新型proNGF突变体及其在生产β-NGF中的用途 |
| WO2017120465A1 (en) * | 2016-01-06 | 2017-07-13 | Massachusetts Eye And Ear Infirmary | Treating cochlear synaptopathy |
| WO2018140792A2 (en) * | 2017-01-27 | 2018-08-02 | Otonomy, Inc. | Neurotrophin mutants for treating hearing loss and other otic disorders |
| EP3406259A1 (en) * | 2017-05-24 | 2018-11-28 | Dompé farmaceutici S.p.A. | Neurotrophins for use in the treatment of hearing loss |
| MA52351A (fr) | 2018-04-27 | 2021-05-26 | Chiesi Farm Spa | Production du facteur de croissance nerveuse (ngf) et de mutéines de celui-ci |
| CN114829384B (zh) * | 2020-11-19 | 2023-12-12 | 舒泰神（北京）生物制药股份有限公司 | 长效神经生长因子多肽及其用途 |
-
2022
- 2022-08-05 EP EP22188990.0A patent/EP4316505A1/en not_active Withdrawn
-
2023
- 2023-08-04 WO PCT/EP2023/071698 patent/WO2024028487A1/en not_active Ceased
- 2023-08-04 IL IL318657A patent/IL318657A/en unknown
- 2023-08-04 EP EP23757837.2A patent/EP4565255A1/en active Pending
- 2023-08-04 AU AU2023317864A patent/AU2023317864A1/en active Pending
- 2023-08-04 CA CA3263975A patent/CA3263975A1/en active Pending
- 2023-08-04 JP JP2025507000A patent/JP2025525989A/ja active Pending
- 2023-08-04 CN CN202380063408.0A patent/CN119836297A/zh active Pending